<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0213264</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1117</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3223</issn>
<issn pub-type="epub">1873-2402</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28340985</article-id>
<article-id pub-id-type="pmc">5373490</article-id>
<article-id pub-id-type="doi">10.1016/j.biopsych.2016.08.031</article-id>
<article-id pub-id-type="manuscript">NIHMS826156</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>AUTOIMMUNITY, AUTOANTIBODIES, AND AUTISM SPECTRUM DISORDERS (ASD)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Edmiston</surname>
<given-names>Elizabeth</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ashwood</surname>
<given-names>Paul</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van de Water</surname>
<given-names>Judy</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Division of Rheumatology/Allergy and Clinical Immunology, University of California, Davis, 451 E. Health Sciences Drive, Suite 6510 GBSF, Davis, CA 95616 USA</aff>
<aff id="A2"><label>2</label>The M.I.N.D. Institute, University of California, Davis, Davis, CA 95616, USA</aff>
<aff id="A3"><label>3</label>NIEHS Center for Childrenâ€™s Environmental Health, University of California, Davis, Davis, CA 95616, USA</aff>
<aff id="A4"><label>4</label>Department of Medical Microbiology and Immunology, University of California, Davis, Davis, CA 95616, USA</aff>
<author-notes>
<corresp id="cor1"><bold>Corresponding Author:</bold> Judy Van de Water; Division of Rheumatology/Allergy and Clinical Immunology; 451 E. Health Sciences Dr., Suite 6510; University of California Davis; Davis, CA 95616 USA. Phone: (530) 752-2154; FAX: 530-752-4669; <email>javandewater@ucdavis.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P18"><bold>Disclosures:</bold> Drs. Edmiston and Ashwood report no biomedical financial interests or potential conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2018</year>
</pub-date>
<volume>81</volume>
<issue>5</issue>
<fpage>383</fpage>
<lpage>390</lpage>
<!--elocation-id from pubmed: 10.1016/j.biopsych.2016.08.031-->
<abstract>
<p id="P1">Autism spectrum disorder (ASD) now affects one in 68 births in the United States and is the fastest growing neurodevelopmental disability worldwide. Alarmingly, for the majority of cases, the causes of ASD are largely unknown, but it is becoming increasingly accepted that ASD is no longer defined simply as a behavioral disorder, but rather as a highly complex and heterogeneous biological disorder. While research has focused on the identification of genetic abnormalities, emerging studies increasingly suggest immune dysfunction is a viable risk factor contributing to the neurodevelopmental deficits observed in ASD. This review summarizes the investigations implicating autoimmunity and autoantibodies in ASD.</p>
</abstract>
<kwd-group>
<kwd>Autism</kwd>
<kwd>autoimmunity</kwd>
<kwd>maternal autoantibodies</kwd>
<kwd>immune</kwd>
<kwd>neurodevelopmental</kwd>
<kwd>pregnancy</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>